CRISPR Journal
Viewpoint: Global moratorium on human gene editing ‘inadvisable’ for 3 reasons, including potential research delays
Heritable genome editing (HGE) of the human germline has potential as a niche assisted reproductive technology. If it can be ...
Why FDA’s proposed gene-editing regulations could stifle CRISPR research on food animals
A 2017 draft Food and Drug Administration guidance proposes mandatory, multigenerational premarket new animal drug evaluation of all “intentional genomic ...